MorphoSys AG - American Depositary Shares (NQ:MOR)

18.96 UNCHANGED

Last Price Updated: 4:00 PM EDT, Aug 2, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MorphoSys AG - American Depositary Shares

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

GSK, MorphoSys' Licensing Partner, Provides Update on ContRAst Phase III Program for Otilimab in Moderate to Severe Rheumatoid Arthritis

October 27, 2022

Via ACCESSWIRE

MorphoSys Reports Preliminary Q3 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022

October 21, 2022

Via ACCESSWIRE

MorphoSys' Monjuvi Shows Long-Term Durable Response In Blood Cancer Settings ↗

September 29, 2022

Via Benzinga

These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win ↗

September 28, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

September 28, 2022

It's time for another dive into the biggest pre-market stock movers as we check out what's going on on Wednesday morning.

Via InvestorPlace

MorphoSys AG: Invitation to MorphoSys' Second Quarter and First Half Year 2022 Results Conference Call on August 4 , 2022

July 28, 2022

Via ACCESSWIRE

MorphoSys AG Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022

July 26, 2022

Via ACCESSWIRE

Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday ↗

September 29, 2022

Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial...

Via Benzinga

Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket ↗

September 28, 2022

Gainers Atlis Motor Vehicles Inc (NASDAQ: AMV) rose 211.7% to $256.00 in pre-market trading after jumping around 199% on Tuesday.

Via Benzinga

MorphoSys Stock Skyrockets On Entering Equity Participation and License Agreements With HIBio ↗

June 14, 2022

Via Benzinga

Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session ↗

September 28, 2022

Gainers

Via Benzinga

Biogen, Eli Lilly And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

September 28, 2022

U.S. stock futures traded lower this morning. Here are some big stocks moving higher in today’s pre-market trading session.

Via Benzinga

MorphoSys AG Reports Second Quarter and First Half 2022 Financial Results

August 03, 2022

From MorphoSys AG

Via Business Wire

Devon Energy Produces A Record Quarter, Dividend Raised By 22%

August 02, 2022

Devon Energy produced another record quarter of profits, as higher volumes and prices provided significant tailwinds to results.

Via MarketBeat

MorphoSys AG: Invitation to MorphoSys' Second Quarter and First Half Year 2022 Results Conference Call on August 4 , 2022

July 28, 2022

Conference Call Alert

From MorphoSys AG

Via AccessWire

MorphoSys Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022

July 26, 2022

PLANEGG/MUNICH, GERMANY / ACCESSWIRE / July 26, 2022 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) today reported preliminary U.S. net product sales of Monjuvi® (tafasitamab-cxix) for the second quarter 2022...

From MorphoSys AG

Via AccessWire

MorphoSys Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022

July 26, 2022

Via ACCESSWIRE

MorphoSys AG Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022

July 26, 2022

Publication of an inside information according to Article 17 para. 1 of the Regulation (EU) No. 596/2014

From MorphoSys AG

Via AccessWire

21 Stocks Moving in Wednesday's Pre-Market Session ↗

June 22, 2022

Gainers Codex DNA, Inc. (NASDAQ: DNAY) rose 64.5% to $3.52 in pre-market trading after declining 10% on Tuesday.

Via Benzinga

Week In Review: Joincare Plans $300-$400 Million IPO On Swiss Exchange ↗

June 18, 2022

Joincare Pharmaceutical of Shenzhen plans to list on the SIX Swiss stock exchange, an unusual venue for a China biopharma. The company said it aims to broaden its financing sources and increase global...

Via Talk Markets

The Daily Biotech Pulse: FDA Committee Backs Moderna Shot For 5-17 Years, 180 Life Sciences Stock Plunges, Pfizer's Posts Disappointing Paxlovid Data ↗

June 15, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

55 Stocks Moving In Wednesday's Mid-Day Session ↗

June 15, 2022

Gainers Sidus Space, Inc. (NASDAQ: SIDU) shares surged 92.4% to $2.77 after the company announced it is part of Collins Aerospace team which was awarded NASA's Exploration Extravehicular Activity...

Via Benzinga

24 Stocks Moving in Wednesday's Pre-Market Session ↗

June 15, 2022

Gainers Boxed, Inc. (NYSE: BOXD) rose 38.3% to $1.95 in pre-market trading. Boxed reported that Director Andrew Pearson bought 150,000 shares at an average price of $1.82 per share.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 14, 2022

Gainers

Via Benzinga

MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210

June 14, 2022

From MorphoSys AG

Via Business Wire

The Daily Biotech Pulse: FDA Nod For Lilly-Incyte's Patchy Hair Loss Treatment, First Regulatory Submission For EQRx, Soleno's Promising Data From Prader-Willi Candidate ↗

June 14, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 13, 2022

Gainers

Via Benzinga

MorphoSys Presents Multiple Analyses of the MANIFEST Phase 2 Trial Investigating the Potential of Pelabresib in the Treatment of Myelofibrosis at EHA 2022

June 10, 2022

From MorphoSys

Via Business Wire

MorphoSys AG Reports Outcome of Annual General Meeting 2022

May 18, 2022

PLANEGG/MUNICH, GERMANY / ACCESSWIRE / May 18, 2022 / MorphoSys AG (FSE:MOR); (NASDAQ:MOR) announced today that its shareholders approved all resolutions proposed by the Company´s Management and...

From MorphoSys AG

Via AccessWire

MorphoSys to Present New Data on Pelabresib and Monjuvi® (tafasitamab-cxix) at the 2022 European Hematology Association (EHA) and American Society of Clinical Oncology (ASCO) Annual Meetings

May 12, 2022

From MorphoSys

Via Business Wire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.